These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37518080)

  • 1. Effect of portable HEPA filters on COVID-19 period prevalence: an observational quasi-interventional study in German kindergartens.
    Falkenberg T; Wasser F; Zacharias N; Mutters N; Kistemann T
    BMJ Open; 2023 Jul; 13(7):e072284. PubMed ID: 37518080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health risk communication and infodemic management in Iran: development and validation of a conceptual framework.
    Bazrafshan A; Sadeghi A; Bazrafshan MS; Mirzaie H; Shafiee M; Geerts J; Sharifi H
    BMJ Open; 2023 Jul; 13(7):e072326. PubMed ID: 37518081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19.
    Izkhakov E; Vilian Y; Buch A; Denysov V; Namouz D; Nathan A; Greenman Y; Ziv-Baran T
    BMC Geriatr; 2023 Aug; 23(1):473. PubMed ID: 37550638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial.
    van der Wal LI; Grim CCA; Del Prado MR; van Westerloo DJ; Boerma EC; Rijnhart-de Jong HG; Reidinga AC; Loef BG; van der Heiden PLJ; Sigtermans MJ; Paulus F; Cornet AD; Loconte M; Schoonderbeek FJ; de Keizer NF; Bakhshi-Raiez F; Le Cessie S; Serpa Neto A; Pelosi P; Schultz MJ; Helmerhorst HJF; de Jonge E;
    Am J Respir Crit Care Med; 2023 Oct; 208(7):770-779. PubMed ID: 37552556
    [No Abstract]   [Full Text] [Related]  

  • 5. N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2.
    Weiss CM; Liu H; Ball EE; Hoover AR; Wong TS; Wong CF; Lam S; Hode T; Keel MK; Levenson RM; Chen WR; Coffey LL
    PLoS One; 2023; 18(8):e0289139. PubMed ID: 37552656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital home monitoring for capturing daily fluctuation of symptoms; a longitudinal repeated measures study: Long Covid Multi-disciplinary Consortium to Optimise Treatments and Services across the NHS (a LOCOMOTION study).
    Mansoubi M; Dawes J; Bhatia A; Vashisht H; Collett J; Greenwood DC; Ezekiel L; O'Connor D; Leveridge P; Rayner C; Read F; Sivan M; Tuckerbell I; Ward T; Delaney B; Muhlhausen W; ; Dawes H
    BMJ Open; 2023 Aug; 13(8):e071428. PubMed ID: 37553189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological survey to estimate SARS-CoV-2 infection and antibody seroprevalence at a large public university: A cross-sectional study.
    Hou CW; Williams S; Taylor K; Boyle V; Bobbett B; Kouvetakis J; Nguyen K; McDonald A; Harris V; Nussle B; Scharf P; Jehn ML; Lant T; Magee M; Chung Y; LaBaer J; Murugan V
    BMJ Open; 2023 Aug; 13(8):e072627. PubMed ID: 37536960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
    Stuurman AL; Carmona A; Biccler J; Descamps A; Levi M; Baum U; Mira-Iglesias A; Bellino S; Hoang U; de Lusignan S; Bonaiuti R; Lina B; Rizzo C; Nohynek H; Díez-Domingo J;
    Front Public Health; 2023; 11():1195409. PubMed ID: 37546295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of spatial transcriptomics analysis using the Visium system for the mouse nasal cavity after intranasal vaccination.
    Toyama S; Honda T; Iwabuchi S; Hashimoto S; Yamaji K; Tokunaga Y; Matsumoto Y; Kawaji H; Miyazaki T; Kikkawa Y; Kohara M
    Front Immunol; 2023; 14():1209945. PubMed ID: 37545501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial - a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial.
    Suk P; Rychlíčková J; Součková L; Kubíčková V; Urbánek K
    BMJ Open; 2023 Jul; 13(7):e071649. PubMed ID: 37518089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early recognition and management of maternal sepsis in Pakistan: a feasibility study of the implementation of FAST-M intervention.
    Ahmed SI; Rind GK; Sikandar R; Raza A; Khowaja BMH; Parveen F; Khan S; Memon N; Jahangir A; Mirza DN; Cheshire J; Dunlop CL; Shakoor S; Barolia R; Sheikh L; Saleem S; Coomarasamy A; Lissauer D
    BMJ Open; 2023 Jul; 13(7):e069135. PubMed ID: 37518083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines.
    Mueller-Enz M; Woopen C; Katoul Al Rahbani G; Haase R; Dunsche M; Ziemssen T; Akgün K
    Front Immunol; 2023; 14():1081933. PubMed ID: 37545513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort.
    Rizzi M; Tonello S; Brinno C; Zecca E; Matino E; Cittone M; Rizzi E; Casciaro GF; D'Onghia D; Colangelo D; Minisini R; Bellan M; Castello LM; Chiocchetti A; Pirisi M; Rigamonti C; Lilleri D; Zavaglio F; Bergami F; Sola D; Sainaghi PP
    Front Immunol; 2023; 14():1185278. PubMed ID: 37545528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infections.
    Tsang TK; Wang C; Fang VJ; Perera RAPM; So HC; Ip DKM; Leung GM; Peiris JSM; Cauchemez S; Cowling BJ
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2304750120. PubMed ID: 37549267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial to evaluate the efficacy of L-carnitine L-tartrate to modulate the effects of SARS-CoV-2 infection.
    Badaro R; Barbosa JDV; de Araujo Neto CA; Machado BAS; Soares MBP; de Senna V; Taddeo M; de Araújo LT; Durkee S; Donninger R; Judge K; Saiyed Z
    Front Nutr; 2023; 10():1134162. PubMed ID: 37545576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory characteristics among patients with COVID-19: a single-center experience from Khartoum, Sudan.
    Mohamed EAA; Mohamed KSA
    Afr Health Sci; 2023 Mar; 23(1):16-22. PubMed ID: 37545971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Outcomes of Patients Requiring Tracheostomy Placement Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Abunasser JJ; Perez O; Wang X; Wang Y; Khouli H; Duggal A
    Crit Care Explor; 2023 Aug; 5(8):e0951. PubMed ID: 37546232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
    Harthaller T; Falkensammer B; Bante D; Huber M; Schmitt M; Benainouna H; Rössler A; Fleischer V; von Laer D; Kimpel J; Würzner R; Borena W
    Front Immunol; 2023; 14():1196988. PubMed ID: 37545492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial.
    Ahmadi S; Mehrabi Z; Zare M; Ghadir S; Masoumi SJ
    Int J Clin Pract; 2023; 2023():5734675. PubMed ID: 37547100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pulmonary rehabilitation program on social disadvantage and physical activity data of postCOVID19 patients: A North-African pilot study.
    Benzarti W; Toulgui E; Ghram A; Rahmani C; Aissa S; Ghannouchi I; Gargouri I; Sayhi A; Knaz A; Ouanes W; Jemni S; Ben Saad H
    F1000Res; 2022; 11():1226. PubMed ID: 37547787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.